Category Archives: Covid-19/2019-nCoV Dr. Lucey Q&A

Phase 3 vaccine trials in the U.S. July 27-Aug. 20/21: A timeline

By on .

By Daniel R. Lucey M.D., MPH, FIDSA Phase 3 COVID-19 vaccine trials in the United States began July 27 with both the Moderna vaccine and the Pfizer/BioNTech vaccine. Given that both vaccine studies are (separately) enrolling 30,000 volunteers (half receive placebo), and given that both require two doses separated by either 28 days (Moderna) or […]

COVID vaccine candidates:  WHO lists 30 in clinical evaluation, six in phase 3 

By on .

By Daniel R. Lucey M.D., MPH, FIDSA Today the World Health Organization updated its DRAFT landscape of COVID-19 candidate vaccines. In a nine-page table format, WHO lists 30 candidate vaccines in clinical evaluation, and 139 candidate vaccines in preclinical evaluation. For all 169 candidate vaccines, information is provided for the name of the developer and […]

COVID-19: Eight key factual statements from Wuhan Institute of Virology’s Dr. Zhengli Shi

By on .

By Daniel R. Lucey M.D., MPH, FIDSA In response to a series of questions asked by Science magazine’s Jon Cohen, the Wuhan Institute of Virology’s internationally-renowned bat coronavirus researcher and collaborator (with scientists in the United States, Singapore, and elsewhere), Dr. Zhengli Shi provided key facts about her work. Among questions she addressed were ones […]

COVID-19: HHS explains “Operation Warp Speed”

By on .

By Daniel R. Lucey M.D., MPH, FIDSA On Friday, The U.S. Department of Health and Human Services posted a succinct 4-page document titled “Explaining Operation Warp Speed.” The summary begins by answering three questions: What is the goal [of OWS]? How will the goal will be accomplished? Who is working on OWS? It moves to […]

COVID-19: FDA Emergency Use Authorization for a vaccine in the fall of 2020 means the time for public dialogue is August      

By on .

By Daniel R. Lucey M.D., MPH, FIDSA The only past U.S. Food and Drug Administration Emergency Use Authorization for any vaccine was in January 2005 for the licensed (since 1970) anthrax vaccine to be used in military personnel “for prevention of inhalation anthrax for individuals between 18 and 65 years of age who are deemed […]

COVID-19: More than 90,000 infections, 500 deaths in U.S. health care personnel

By on .

By Daniel Lucey MD, MPH, FIDSA Today, more somber statistics on the pandemic posted on the U.S. Centers Disease Control COVID-19 website: Since the previous day, 54,357 new cases of SARS-CoV-2 infection were documented (of the total 2,679, 230 US cases in 2020, accordingly to the CDC). Not surprisingly, as the number of hospitalizations is […]

COVID-19: Eight questions for the WHO team going to China next week to investigate pandemic origins

By on .

By Daniel R. Lucey M.D., MPH, FIDSA Today the South China Morning Post reported that on Monday the World Health Organization Director General Tedros Adhanom Gehbreysus stated “We can fight the virus better when we know everything about the virus, including how it started . . .We will be sending a team next week to […]

COVID-19: China approves vaccine for use by military only without phase III study

By on .

By Daniel R. Lucey M.D., MPH, FIDSA Today China approved a Covid-19 vaccine, for use only by its military. Importantly, however, this approval occurred despite the vaccine not having undergone a phase III efficacy study. As reported by Josephine Ma in the South China Morning Post, this vaccine was developed by the company CanSino Biologics […]

COVID-19: In Beijing a new outbreak linked with large market “Xinfadi” 

By on .

By Daniel R. Lucey M.D., MPH, FIDSA In a growing series of events in Beijing over the past 48 hours a new outbreak has been reported with an epidemiological link to the largest food market, called “Xinfadi”, in the city. The main China Center for Disease Control in Beijing, and the overarching China National Health […]

COVID-19: Will high-tide waves and low-tide waves continue across America? Over 20,000 new cases and 800 deaths since yesterday

By on .

By Daniel R. Lucey M.D., MPH FIDSA As the number of reported people confirmed with COVID-19 in the United States crosses 2 million and the number of deaths crosses 113,000 (reference: Johns Hopkins University), the U.S. Centers for Disease Control and Prevention website reports 20,486 new cases and 834 deaths since yesterday.  What will tomorrow, […]